Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Evaluation of novel PET ligands (+)N-[C-11]methyl-3-piperidyl benzilate ([C-11](+)3-MPB) and its stereoisomer [C-11](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: A PET study in comparison with [C-11]4-MPB
Autore:
Tsukada, H; Takahashi, R; Miura, S; Nishiyama, S; Kakiuchi, T; Ohba, H; Sato, K; Hatazawa, J; Okudera, T;
Indirizzi:
Hamamatsu Photon KK, Cent Res Lab, Shizuoka 4348601, Japan Hamamatsu Photon KK Shizuoka Japan 4348601 Lab, Shizuoka 4348601, Japan Res Inst Brain & Blood Vessels Akita, Dept Radiol & Nucl Med, Akita, JapanRes Inst Brain & Blood Vessels Akita Akita Japan Nucl Med, Akita, Japan
Titolo Testata:
SYNAPSE
fascicolo: 2, volume: 39, anno: 2001,
pagine: 182 - 192
SICI:
0887-4476(200102)39:2<182:EONPL(>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; UNANESTHETIZED MONKEYS; ALZHEIMERS-DISEASE; C-11 RACLOPRIDE; RHESUS-MONKEY; BINDING; SCOPOLAMINE; QUANTIFICATION; RADIOLIGAND;
Keywords:
N-[C-11]methyl-3-piperidyl benzilate; muscarinic receptor, monkey brain; PET;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
46
Recensione:
Indirizzi per estratti:
Indirizzo: Tsukada, H Hamamatsu Photon KK, Cent Res Lab, 5000 Hirakuchi, Shizuoka 4348601, Japan Hamamatsu Photon KK 5000 Hirakuchi Shizuoka Japan 4348601 apan
Citazione:
H. Tsukada et al., "Evaluation of novel PET ligands (+)N-[C-11]methyl-3-piperidyl benzilate ([C-11](+)3-MPB) and its stereoisomer [C-11](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: A PET study in comparison with [C-11]4-MPB", SYNAPSE, 39(2), 2001, pp. 182-192

Abstract

The novel muscarinic cholinergic ligands (+)N-[C-11] methyl-3-piperidyl benzilate ([C-11](+)3-MPB) and its stereoisomer [C-11](-)3-MPB were evaluatedin comparison with [11C]4-MPB in the brains of conscious monkeys (Macaca mulatta) using high-resolution positron emission tomography (PET). The regional distribution patterns of [C-11](+)3-MPB and [C-11]4-MPB at 60-91 min postinjection were almost identical: highest in the striatum and occipital cortex; intermediate in the temporal and frontal cortices, cingulate gyrus, hippocampus, and thalamus; lower in the pens; and lowest in the cerebellum. The uptake of [C-11]( +)3-MPB in all regions was higher and the dynamic range of regional uptake differences of [C-11](+)3-MPB was better than those of [C-11]4-MPB. The levels of [C-11](-)3-MPB were much lower in all regions of the brain than [C-11](+)3-MPB and [C-11]4-MPB. Administration of scopolamine, a muscarinic cholinergic antagonist, at a dose of 50 mug/kg reduced the radioactivity of [C-11](+)3-MPB and [11C]4-MPB in all regions except thecerebellum. Time-activity curves of [C-11](+)3-MPB peaked in all regions, while these of [C-11]4-MPB showed gradual increases with time in all regions except the thalamus, pens, and cerebellum. Two graphical analyses (Logan plot and Patlak plot) with plasma radioactivity as an input function into the brain were applied to evaluate receptor binding in vivo. [C-11](+)3-MPB showed linear regression curves on Logan plot analysis and nonlinear curveson Patlak plot in all regions, suggesting that [C-11](+)3-MPB bound reversibly to the muscarinic receptors. The in vivo binding parameters as well asuptake at 60-91 min postinjection of [C-11](+)3-MPB were consistent with muscarinic receptor density in the brain as reported in vitro. (C) 2001 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/20 alle ore 16:13:41